EOS Remediation Secures Patent Rights for Vadose Zone Remediation
An Exclusive Patent License Agreement was signed between EOS Remediation, LLC, a developer and manufacturer of advanced technologies for groundwater restoration, and Savannah River Nuclear Solutions, LLC. This royalty-based agreement grants EOS Remediation an exclusive world-wide license to manufacture, use, and sell the VOS™, a "Thixotropic Gel for Vadose Zone Remediation," a technology developed at the U.S. Department of Energy's Savannah River National Laboratory, which is operated for DOE by SRNS.

Gary Birk, Director of EOS Remediation said that this license agreement with Savannah River Nuclear Solutions will expand our strong foundation of intellectual property and working with the outstanding researchers will provide us more design freedom to develop the next generation of bioremediation technologies and solutions in keeping with the demands of this ever-expanding environmental sector.

Brian Riha at the Savannah River National Laboratory has developed VOS™ specifically for remediation of organic compounds in the vadose zone which are otherwise difficult to target. VOS™ employs sustainable "green" chemistry and represents a significant advancement in the treatment of unsaturated soils by using unique thixotropic nature of this gel which forms a stable oil/water suspension that remains in place after injection into the vadose zone for long time in the soil allowing moisture, nutrients and food in the formulation to become available to microbes and biotransform the contaminants previously considered untouchable.

Early results have shown that the VOS™ Technology have applications to a number of environmental problems and can cost-effectively turn land once deemed unusable into productive real estate.

IP News

01-01-2009

Bio Remediation
PatInt News
PatInt News
Your weekly informaion portal
Bio Fuel
Bio Remediation
Bio Materials
Bio Medicine
Green Polymers
Composite Material
Catalysts
|
|
|
|
|
|

This portal is maintained by PatInt Solutions
Home
This site is best viewed with Internet Explorer 6.0 or higher, Firefox 2.0 or higher at a minimum screen resolution of 1024x768.
Copyright PatIntNews.Com 2007. All Right Reserved